These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21831400)

  • 21. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apathy and depression in Parkinson disease.
    Oguru M; Tachibana H; Toda K; Okuda B; Oka N
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):35-41. PubMed ID: 20015839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.
    Prange S; Metereau E; Maillet A; Lhommée E; Klinger H; Pelissier P; Ibarrola D; Heckemann RA; Castrioto A; Tremblay L; Sgambato V; Broussolle E; Krack P; Thobois S
    Mov Disord; 2019 Nov; 34(11):1644-1654. PubMed ID: 31309609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy and depression scales in Parkinson's disease: are they good enough?
    Schrag A
    J Neurol Sci; 2011 Nov; 310(1-2):216-9. PubMed ID: 21689829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?
    Rosenberg PB; Nowrangi MA; Lyketsos CG
    Mol Aspects Med; 2015; 43-44():25-37. PubMed ID: 26049034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minor depression and brain perfusion images in Parkinson's disease.
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Mov Disord; 2006 Aug; 21(8):1169-74. PubMed ID: 16685687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Apathy in Parkinson's disease. Impairment in quality of life].
    Bottini Bonfanti A; Etcheverry JL; Persi GG; Zezza H; Starkstein S; Gatto EM
    Medicina (B Aires); 2009; 69(2):253-8. PubMed ID: 19435698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review.
    Alzahrani H; Venneri A
    J Neurol Sci; 2015 Sep; 356(1-2):32-44. PubMed ID: 26123201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence.
    Alzahrani H; Antonini A; Venneri A
    J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parkinson's disease: psychological and behavioral disorders].
    Delgadillo-Iniguez D; Corvol JC; Gély-Nargeot MC; Lacomblez L
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S11-6. PubMed ID: 23631043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Falcón C; Bargalló N; Valldeoriola F; Junqué C
    Mov Disord; 2008 Dec; 23(16):2335-43. PubMed ID: 18785653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are dementia and depression in Parkinson's disease related?
    Lieberman A
    J Neurol Sci; 2006 Oct; 248(1-2):138-42. PubMed ID: 16814323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial remapping of cortico-striatal connectivity in Parkinson's disease.
    Helmich RC; Derikx LC; Bakker M; Scheeringa R; Bloem BR; Toni I
    Cereb Cortex; 2010 May; 20(5):1175-86. PubMed ID: 19710357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of apathy in Parkinson's disease.
    Dujardin K; Sockeel P; Devos D; Delliaux M; Krystkowiak P; Destée A; Defebvre L
    Mov Disord; 2007 Apr; 22(6):778-84. PubMed ID: 17290451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of psychiatric complications of Parkinson's disease].
    Fénelon G
    Rev Prat; 2005 Apr; 55(7):733-9. PubMed ID: 15966416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separate neural representations of depression, anxiety and apathy in Parkinson's disease.
    Dan R; Růžička F; Bezdicek O; Růžička E; Roth J; Vymazal J; Goelman G; Jech R
    Sci Rep; 2017 Sep; 7(1):12164. PubMed ID: 28939804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.
    Thobois S; Prange S; Sgambato-Faure V; Tremblay L; Broussolle E
    Curr Neurol Neurosci Rep; 2017 Aug; 17(10):76. PubMed ID: 28822071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.